In NSCLC, the non-invasive measurement of PD-L1 expression in pleural EpCAM-positive cells (PECs), using the CellSearch® technology, provides prognostic information and may improve the diagnostic accuracy of malignant pleural effusion (MPE) [41]. The gene discussed is CD274; the disease is non-small cell lung carcinoma.